Why Inhibikase Therapeutics ( IKT ) Stock Is Up 50% Today - Inhibikase Therapeutics ( NASDAQ:IKT )
Inhibikase Therapeutics Inc IKT shares are trading higher by 31.1% to $1.56 during Wednesday's session after the company announced the pricing of an approximately $110 million private placement financing.
| Ticker |
Sentiment |
Impact |
|
AWON
|
Neutral
|
10 %
|
|
IKT
|
Somewhat Bullish
|
46 %
|
|
BX
|
Neutral
|
10 %
|
|
BRK-A
|
Somewhat Bullish
|
10 %
|
